한글목차

혈당 측정기 동향 및 전망

세계 혈당 측정기 시장은 2024년부터 2030년까지 8.9%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년까지 약 305억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 전 세계 당뇨병 유병률 증가, 의료 인프라 비용 증가, 당뇨병 관리에 대한 지식 증가입니다. 세계 혈당 측정기 시장의 미래는 시설 판매, 병원, 클리닉, 소매 판매, 병원 약국, 소매 약국 및 온라인 약국 시장의 기회로 인해 유망합니다.

혈당 측정기 시장 인사이트

Lucintel의 예측에 따르면, 자가 혈당 측정 시스템은 사용하기 쉽고 가격이 저렴하기 때문에 예측 기간 동안 가장 큰 부문으로 남을 것으로 보입니다.

이 시장에서 병원 약국은 의료 전문가에게 편리하다는 점에서 가장 큰 시장으로 남을 것으로 보입니다.

북미는 높은 당뇨병 유병률로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계 혈당 측정기 시장은 2030년까지 약 305억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 전망은?

A2. 세계 혈당 측정기 시장은 2024년부터 2030년까지 연평균 8.9%의 성장률을 보일 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 무엇인가?

A3.이 시장의 주요 촉진요인은 전 세계 당뇨병 유병률 증가, 의료 인프라 비용 상승, 당뇨병 관리에 대한 지식 증가입니다.

Q4. 시장의 주요 부문은?

A4. 혈당 측정기 시장 전망은 시설 판매, 병원, 진료소, 소매 판매, 병원 약국, 소매 약국, 온라인 약국 시장에서의 기회로 인해 유망합니다.

Q5. 시장의 주요 기업은?

A5. 주요 혈당 측정기 기업은 다음과 같습니다.

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Q6. 향후 가장 큰 시장 부문은?

A6.Lucintel은 자가 혈당 측정 시스템이 사용하기 쉽고 저렴한 가격으로 인해 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상했습니다.

Q7. 향후 5년간 가장 큰 시장으로 성장할 것으로 예상되는 지역은?

A7. 북미는 높은 당뇨병 유병률로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

Q8. 보고서 커스터마이징이 가능한가?

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 혈당 측정기 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 혈당 측정기 시장 동향(2018-2023)과 예측(2024-2030)
• 제품별 세계의 혈당 측정기 시장
  • 연속 혈당 측정기
  • 자기 혈당 측정 시스템
• 기술별 세계의 혈당 측정기 시장
  • 침습적
  • 비침습적
• 유형별 세계의 혈당 측정기 시장
  • 웨어러블
  • 비웨어러블
• 유통 채널별 세계의 혈당 측정기 시장
  • 시설 판매
  • 병원
  • 클리닉
  • 소매 판매량
  • 병원 약국
  • 소매 약국
  • 온라인 약국
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2030년)

• 지역별 세계의 혈당 측정기 시장
• 북미의 혈당 측정기 시장
• 유럽의 혈당 측정기 시장
• 아시아태평양의 혈당 측정기 시장
• 기타 지역의 혈당 측정기 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 혈당 측정기 시장 성장 기회
  • 기술별 세계의 혈당 측정기 시장 성장 기회
  • 유형별 세계의 혈당 측정기 시장 성장 기회
  • 유통 채널별 세계의 혈당 측정기 시장 성장 기회
  • 지역별 세계의 혈당 측정기 시장 성장 기회
• 세계의 혈당 측정기 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 혈당 측정기 시장 능력 확대
  • 세계 혈당 측정기 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증과 라이선싱

제7장 유력 기업 개요

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

영문목차

Glucometer Trends and Forecast

The future of the global glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets. The global glucometer market is expected to reach an estimated $30.5 billion by 2030 with a CAGR of 8.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

A more than 150-page report is developed to help in your business decisions.

Glucometer by Segment

The study includes a forecast for the global glucometer by product, technique, type, distribution channel, and region.

Glucometer Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Continuous Glucose Monitoring Devices
• Self-Monitoring Blood Glucose Systems

Glucometer Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

• Invasive
• Non-Invasive

Glucometer Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Wearable
• Non-Wearable

Glucometer Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Institutional Sales
• Hospitals
• Clinics
• Retail Sales
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Glucometer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Glucometer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glucometer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glucometer companies profiled in this report include-

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Glucometer Market Insights

Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Within this market, hospital pharmacies will remain the largest segment due to convenience to healthcare professionals.

North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Features of the Global Glucometer Market

Market Size Estimates: Glucometer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glucometer market size by various segments, such as by product, technique, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Glucometer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, technique, type, distribution channel, and regions for the glucometer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glucometer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the glucometer market size?

Answer: The global glucometer market is expected to reach an estimated $30.5 billion by 2030.

Q2. What is the growth forecast for glucometer market?

Answer: The global glucometer market is expected to grow with a CAGR of 8.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the glucometer market?

Answer: The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

Q4. What are the major segments for glucometer market?

Answer: The future of the glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key glucometer market companies?

Answer: Some of the key glucometer companies are as follows.

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Q6. Which glucometer market segment will be the largest in future?

Answer: Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Q7. In glucometer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the glucometer market by product (continuous glucose monitoring devices and self-monitoring blood glucose systems), technique (invasive and non-invasive), type (wearable and non-wearable), distribution channel (institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glucometer Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Glucometer Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Glucometer Market by Product
  • 3.3.1: Continuous Glucose Monitoring Devices
  • 3.3.2: Self-Monitoring Blood Glucose Systems
• 3.4: Global Glucometer Market by Technique
  • 3.4.1: Invasive
  • 3.4.2: Non-Invasive
• 3.5: Global Glucometer Market by Type
  • 3.5.1: Wearable
  • 3.5.2: Non-Wearable
• 3.6: Global Glucometer Market by Distribution Channel
  • 3.6.1: Institutional Sales
  • 3.6.2: Hospitals
  • 3.6.3: Clinics
  • 3.6.4: Retail Sales
  • 3.6.5: Hospital Pharmacies
  • 3.6.6: Retail Pharmacies
  • 3.6.7: Online Pharmacies
  • 3.6.8: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Glucometer Market by Region
• 4.2: North American Glucometer Market
  • 4.2.2: North American Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.2.3: North American Glucometer Market by Type: Wearable and Non-Wearable
  • 4.2.4: North American Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
• 4.3: European Glucometer Market
  • 4.3.1: European Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
  • 4.3.2: European Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.3.3: European Glucometer Market by Type: Wearable and Non-Wearable
  • 4.3.4: European Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
• 4.4: APAC Glucometer Market
  • 4.4.1: APAC Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
  • 4.4.2: APAC Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.4.3: APAC Glucometer Market by Type: Wearable and Non-Wearable
  • 4.4.4: APAC Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
• 4.5: ROW Glucometer Market
  • 4.5.1: ROW Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
  • 4.5.2: ROW Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.5.3: ROW Glucometer Market by Type: Wearable and Non-Wearable
  • 4.5.4: ROW Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Glucometer Market by Product
  • 6.1.2: Growth Opportunities for the Global Glucometer Market by Technique
  • 6.1.3: Growth Opportunities for the Global Glucometer Market by Type
  • 6.1.4: Growth Opportunities for the Global Glucometer Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Glucometer Market by Region
• 6.2: Emerging Trends in the Global Glucometer Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Glucometer Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glucometer Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Promega Corporation
• 7.3: Agilent Technologies
• 7.4: Bio-Rad Laboratories
• 7.5: QIAGEN
• 7.6: Merck
• 7.7: B.D.
• 7.8: Sanofi
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: Abbott